Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000533760 | SCV000654796 | benign | Immunodeficiency, common variable, 10 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000533760 | SCV001477808 | benign | Immunodeficiency, common variable, 10 | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003424141 | SCV004127273 | benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | NFKB2: BS1, BS2 |
Prevention |
RCV003905446 | SCV004727293 | benign | NFKB2-related condition | 2019-08-28 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |